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Human Malignant Glioblastoma U-373 Cell Line
Abstract
Glioblastoma is one of the most combative astrocytoma that is resistant to chemotherapy and
radiotherapy. This resistance makes it very difficult to treat. However, researches have shown that
nanoparticles especially C60 hydrofullerene have antioxidant and anticancer activity. The effect of C60
hydrofullerene in cancer has been extensively studied; however, the potential regulation of autophagy and
modulation of the Glial Fibrillary Acidic Protein (GFAP) gene has not been addressed in glioblastomas.
Glioblastoma U-373 cell was treated with 0.5 µM of C60 hydrofullerene and/or 1 mM of hydrogen
peroxide (H2O2) for 24 hours. This study demonstrated that C60 hydrofullerene and H2O2 significantly
decreased cell proliferation. The gene expression and conversion of LC3-II/LC3-I were significantly
induced in the separate and combined treatments. The immunofluorescent results observe that H2O2
dramatically inhibits the expression of GFAP. However, when the cells were treated with both H2O2 and
C60 hydrofullerene, GFAP expression was significantly restored. The anti-proliferative effects of C60
hydrofullerene and H2O2 are shown in the results. Both treatments induced LC3-based autophagy and
H2O2 was down regulated GFAP.
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Abstract
Glioblastoma is one of the most combative astrocytoma that is resistant to chemotherapy and radiotherapy. This
resistance makes it very difﬁcult to treat. However, researches have shown that nanoparticles especially C60 hydrofullerene have antioxidant and anticancer activity. The effect of C60 hydrofullerene in cancer has been extensively
studied; however, the potential regulation of autophagy and modulation of the Glial Fibrillary Acidic Protein (GFAP)
gene has not been addressed in glioblastomas. Glioblastoma U-373 cell was treated with 0.5 mM of C60 hydrofullerene
and/or 1 mM of hydrogen peroxide (H2O2) for 24 hours. This study demonstrated that C60 hydrofullerene and H2O2
signiﬁcantly decreased cell proliferation. The gene expression and conversion of LC3-II/LC3-I were signiﬁcantly induced
in the separate and combined treatments. The immunoﬂuorescent results observe that H2O2 dramatically inhibits the
expression of GFAP. However, when the cells were treated with both H2O2 and C60 hydrofullerene, GFAP expression
was signiﬁcantly restored. The anti-proliferative effects of C60 hydrofullerene and H2O2 are shown in the results. Both
treatments induced LC3-based autophagy and H2O2 was down regulated GFAP.
Keywords: Glioblastoma, C60 hydrofullerene, Hydrogen peroxide, Autophagy, GFAP

1. Introduction

G

lioblastoma was discovered by Burns in 1800
and Abernethy in 1804 [1]. It is the most
aggressive grade IV form of glioma [2,3], which
arises from glial cells [2]. It is characterized by its
fast-growing, rapid invading ability into the adjacent tissue [2], it is more common among men and
approximately 57% of all astrocytic tumors are
glioblastoma [3,4]. However, glioblastoma is resistant to chemotherapy and radiotherapy [5]. The
treatment of glioblastoma is the removal of the
tumor followed by radiotherapy and chemotherapy
[2,4]. Researchers are continuing to ﬁnd out more
ways to treat patients. These studies have observed

nanoparticles having anti-cancer effects on glioblastoma [6,7], but there is not enough data to fully
understand about the ways that nanoparticles affect
glioblastoma. Further research may aid in making
carbon nanoparticles as potential factors for anticancer therapy [8].
Nanomaterials have large applications in scientiﬁc
and medical research because of their external dimensions, high chemical properties, and physical
activities [9]. Nanomaterials have various characteristics that make them beneﬁcial. They do not
aggregate in tissues at a high rate and have a high
shelf-life rate. When consumed by non-healthy cells
compared to the normal cells, they can induce
abnormal apoptosis, pro-inﬂammatory effect, and
augment oxidative stress [7].
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Among nanomaterials, C60 hydrofullerene is
potent for its anticancer, cytoprotective, and cytotoxic effects [7]. It does not affect normal cells and
tissue at low concentrations [6]. Nanocrystalline C60
particularly, has a cytotoxic effect against resistant
chemotherapy glioma that is dependent and independent of oxidative stress [7]. The data about hydrated C60 hydrofullerene on glioblastoma is
limited; nevertheless, some research has shown
anti-proliferative effects of C60 hydrofullerene. The
study observed that C60 derivatives signiﬁcantly
inhibited glioblastoma's growth [10]. In addition,
researchers observed different anti-proliferative
mechanisms of C60 hydrofullerene on cancer cell
lines HeLa, A549, and MCF-7 [11]. Regarding antiproliferation activity, recent studies demonstrated
dual roles of C60 hydrofullerene on cancer cells and
have cytotoxic effects [12]. On the other hand, C60
hydrofullerene has protective properties such as
diminishing cytotoxicity. For example, studies have
shown the protective effect of fullerene in rat brains
exposed to alcohol by maintaining the expression of
Glial Fibrillary Acidic Protein (GFAP) [13,14].
GFAP is the essential member of intermediate
ﬁlament proteins type III that participates in the
formation of the cytoskeleton building of astrocytes
[15,16]. GFAP is expressed in glial cells and in the
glioblastoma cell. It is necessary for cell survival
[17], mitosis [15,17], normal cell functions, cell
apoptosis, cell prognosis [17], cell migration [15,17],
cell motility and attaching to the glutamate transporter in the cell membrane [15], and astrocytic
reactive response [16].
GFAP has been used to clinically diagnose glioma
for many years [17e20]. A high level of GFAP protein was found in patients with glioblastoma grade
II when compared to grades III and IV [21,22]. A low
level of GFAP protein expression was found in
glioblastoma grade IV [15,23] and the level of GFAP
most likely does not reﬂect the differentiation state
of glioblastoma [15]. On the other hand, a high level
of GFAP-d protein (the most abundant isoform of
GFAP protein) was anticipated in glioma grade IV
compared to low-grade glioma [19]. The study also
demonstrated that glioma with a high level of GFAP
is more invasive [24]. The progression and expression of GFAP positive glioblastoma is higher than
GFAP negative glioblastoma [15].
This study was designed to elaborate on the effects of C60 hydrofullerene nanoparticles and H2O2
on autophagy in human malignant glioblastoma
cells. Because of, reviews demonstrated that Glioblastoma is resistant to apoptosis [25], C60 induces
autophagy [26] and autophagy is hypothesized to
have dual role such as; anti-cancer activity and
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cancer protective role [27]. The questions are, does
C60 hydrofullerene can play as an anticancer agent?
Does it recover the cells when treated with cytotoxic
agent through intermediate ﬁlament protein protection? Does C60 hydrofullerene induce LC3-based
autophagy whereas Glioblastoma is resistant to
apoptosis?

2. Methods and materials
2.1. Cell culture
Human Glioblastoma U-373 Cell Line was acquired from ATCC organization (ATCC, USA). The
U-373 cell was seeded in a 75 cm2 ﬂask (SigmaAldrich, Germany) with a DMEM medium containing 10% fetal bovine serum, 64 mg/ml penicillin,
and 0.1 mg/ml streptomycin antibiotic solution. It
was incubated in a humidiﬁed incubator (Esco,
Singapore) at 5% CO2 at 37  C. The cells were
incubated under these conditions throughout the
experiment unless stated otherwise. The medium
was changed every 48 hours.
2.2. Treatment
This study is designed to treat the glioblastoma U373 cell line with 0.5 mM C₆₀ hydrofullerene and/or 1
mM hydrogen peroxide for 24 hours.
2.3. Cell proliferation assay (MTT)
To analyze cell proliferation, MTT cell proliferation set (Roche, Germany) was used [28]. The glioblastoma cell was seeded in 96 well-plates (SigmaAldrich, Germany) containing 6  103 cells/well.
The cells were incubated overnight as mentioned
before and then treated with its respective treatment. The ﬁrst MTT reagent (10 ml) was added and
the cells were gestated in a humidiﬁed incubator for
4 hours in the dark. Then the solubilization reagent
was added (100 ml/well). The plate was allowed to
stand overnight away from light. The absorbance of
formazan crystals was measured by using an ELISA
reader (Molecular devices LLC, USA). The ELISA
reader took measurements at a wavelength of
550e600 nm along with a reference wavelength at
more than 650 nm. Finally, the cell viability was
extracted from cell proliferation MTT assay result
[28].
2.4. Western blot assay
Fresh lysis buffer (RIPA) containing 1 mM proteinase inhibitor, leupeptin and pepstatine was used
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to prepare the total protein [29]. Loading buffer was
added to the sample and warmed up to 94  C. Then,
20 mg from each sample was loaded to 12% SDSpolyacrylamide gel. The separated polypeptide
bands were transferred to the PVDF membrane
(Millipore, Germany) and blocked by using 5%
skimmed milk. The membrane was bathed with
primary antibodies (LC3 diluted 1:1000, b-actin
1:2500) (Santacruz, USA), 24 hours at 4 then washed
out by PBS solution 5 times and placed in tubes
containing different secondary antibodies (antimouse and anti-rabbit 1:5000) (Advansta, USA), for
an hour at 25  C. The signals were developed by the
chemiluminescence X-ray method (Carestream,
USA).
2.5. Immuno-ﬂuorescent assay
5  105 cells/well were cultured in a 96-well plate,
incubated overnight, and then treated. The treated
cells were ﬁxed by 4% paraformaldehyde then
washed with PBS at room temperature. It incubated
in FBS containing GFAP primary antibody (anirabbit 1:500, Abcam) overnight at 4  C. After the
primary antibody had been washed out with PBS,
the cells were covered with the solution containing
secondary antibody (anti-mouse 1:1000 diluted,
Abcam) for 2 hours at room temperature. The cells
were washed and incubated at room temperature
with a blocking solution containing nuclear dye
DAPI for 15 minutes. The last step was to wash the
cells with PBS. The images were obtained using a
Nikon microscope (Nikon, Japan) connected to a
computer and armed with a ﬂuorescent illuminator
(Rockland, USA).
2.6. Statistical analyses
The data was evaluated in the Graph Pad Prism 9
soft program. The result was analyzed by one-way
ANOVA Tukey nonparametric. The Densitometry
analysis was performed in ImageJ software (USA)
and normalized against its respective load control.
Each treatment was replicated three times.

3. Results
3.1. C60 hydrofullerene and H2O2 inhibited cell
proliferation
Cell proliferation of normal and damaged cells
were measured by MTT assay, and cell viability was
extracted from MTT assay result [28]. The results
show that nanoparticle C60 hydrofullerene and
H2O2 have an anti-proliferation effect against the U-

373 cell line. The obtained results and the MTT
assay were observed that Malignant glioblastoma
cell proliferation was inhibited when treated with
0.5 mM C60 hydrofullerene (**p < 0.05) and cell
viability decreased approximately 15%. The 1
mM H2O2 inhibited cell proliferation (*p < 0.05) and
cell viability decreased approximately 13%. The
combined dose of C60 hydrofullerene and H2O2
greatly
inhibited
U-373
cell
proliferation
(***p < 0.05) and cell viability decreased by mean
approximately 26%. The results are shown in Fig. 1.
3.2. C60 hydrofullerene and H2O2 induced
autophagy
To elaborate on the effect of C60 hydrofullerene
and H2O2 on autophagy, the level of LC3 was
measured by the Western blot technique. The results of our study observed the induction effect of
treatments on LC3 protein in the Malignant Glioblastoma U-373 cell line. C60 hydrofullerene (0.5
mM) does not have a signiﬁcant effect on LC3
expression. On the other hand, the LC3 protein was
induced when exposed to 1 mM H2O2 for 24 hours
(*p < 0.05) and the combined dose of (C60 hydrofullerene and H2O2) induced the expression and
conversion of LC3 protein (*p < 0.05) as shown in
Fig. 2.
3.3. C60 hydrofulleren prevents decline of GFAP
The GFAP in the U-373 malignant glioma cell did
not change signiﬁcantly when treated with C60
hydrofullerene. On the other hand, the pictures
presented show that C60 hydrofullerene prevents
decline of GFAP caused by H2O2 exposure. Therefore, C60 hydrofullerene ameliorates the disturbance in glial cytoskeleton as shown in Fig. 3.

4. Discussion
In our study, a unique discovery was observed
about the effect of C60 hydrofullerene on the human
malignant glioblastoma U-373 cell line. We found
that C₆₀ hydrofullerene at a low dose (0.5 mM) with
H₂O₂ separately and combined inhibited malignant
glioma cell proliferation in a dose-dependent
manner. The highest inhibition among these treatments was noticed in the combined treatment of C60
hydrofullerene and H2O2 (***p < 0.05). The results
in our study agree with other published studies.
One study mentioned that H2O2 (125 mM) inhibited
cell proliferation in C6 glioma cell line [30]. Kim et al.
2012, said that 600e900 mM H2O2 decreased cell
viability [31]. The high dose (400e1000) mm of H2O2
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Fig. 1. The level of glioma U-373 cell proliferation (A) and Cell viability (B) of control and treated cells with C60 hydrofullerene 0.5 mM and H2O2 1
mM in vitro. n ¼ 3.

Fig. 2. The Western blot result for LC3 protein. n ¼ 3.
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Fig. 3. The immunoﬂuorescent pictures of GFAP protein in Human Malignant Glioblastoma U-373 cell line treated with C60 hydrofullerene and
H2O2. n ¼ 3.

signiﬁcantly reduced cell viability in the HepG2 cell
line [27]. As we illustrated in our results, C60
hydrofullerene has an anti-proliferative effect
against the U-373 cell line [32]. In addition, the
photoexcited C60 and H2O2 (both about 50 mm)
inhibited 50% cell viability in leukemic cells after 24
hours [33]. In Ershova et al. 2016, a high dose of C60
hydrofullerene signiﬁcantly decreased the number
of human embryonic lung ﬁbroblasts cells [34].
Prylutska et al., 2011 and 2014, demonstrated the C60
hydrofullerene effect against tumor growth in mice
transplanted lung cancer [6].
In this study, a high level of LC3 expression was
observed in the U-373 cell line when treated with
H2O2 and C60 hydrofullerene. To examine the effect
of H2O2 and C60 hydrofullerene, the Western blot
experiment was performed. The result demonstrated that the H2O2 dose and combined dose of
H2O2 and C60 hydrofullerene signiﬁcantly induced
autophagy through LC3 protein when compared to
the control group (*p < 0.05, **p < 0.05). However,
the C60 hydrofullerene dose alone, does not significantly regulate the expression and conversion of
LC3 protein as shown in Fig. 2. Recent studies
supported our results. The ADS-I increased the
autophagy in the U-373 glioblastoma cell line
through LC3-II protein [35]. In addition, the conversion of LC3-I to LC3-II induced autophagy in the
U-373 glioblastoma cell line [36]. One study
demonstrated autophagic cell death in the U-251
malignant glioma cell line by up-regulating LC3-II
[37]. Another published study demonstrated that

H2O2 after 12 hours induced autophagy and upregulated LC3-II protein [38]. Considerable evidence from the references demonstrate that H2O2
treatment induced autophagy and increased LC3-II
and GFP-LC3 puncta in human malignant glioma
[39]. Finally, the results from our study coincides
with the study published by Kong et al., 2011 that
1mM of H₂O₂ induced autophagy in human malignant glioma U-251 cell line [40] and autophagic cell
death was seen in U-373 cell line based on upregulation of LC3 protein when treated with H₂O₂
and C₆₀ hydrofullerene [41].
In our study, the U-373 cell line was used to
determine the effect of H₂O₂ and C60 hydrofullerene.
Glioblastoma cells express the GFAP protein [15]
and might play a vigorous role in glioblastoma
malignancy [21,42], elaborate adhesion, and proliferation [42]. In our previous ﬁndings, C60 hydrofullerene inhibited GFAP expression while C60
hydrofullerene improves GFAP reduction [32]. One
study demonstrated that C60 hydrofullerene inhibited loss of cytoskeleton GFAP in rat brain astrocytic
cells against alcoholic impact Prischepa et al., 2015
discussed that C60 hydrofullerene restored GFAP
expression in STZ-Diabetic rat retina [14,43]. Huang
et al., 2018 said that GFAP is restored in H2O2
degenerated rat retina when treated with C₆₀
nanoparticle [44]. There were similarities in our results; H2O2 dramatically inhibited GFAP expression
when compared to the control group and even more
so when compared to the C60 hydrofullerene group.
On the other hand, C60 hydrofullerene slightly
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inhibited GFAP expression, but ameliorates GFAP
expression when the cells were treated with H2O2
and C60 hydrofullerene for 24 hours.

5. Conclusion
C60 hydrofullerene and H2O2 have anti-proliferative effects separately and in combined dose. C60
hydrofullerene can act as an anti-cytotoxic against
the hydrogen peroxide effects, which partially
ameliorates GFAP protein. In addition, it could be
used in the future as an anti-cancer treatment and a
cytoprotective drug for normal cells against various
diseases but needs further investigation.
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